Oct. 18 (Bloomberg) -- AstraZeneca Plc, the U.K.'s second- largest drugmaker, had a patent protecting the manufacturing of its Symbicort asthma inhaler revoked by European regulators.
Oct. 18 (Bloomberg) -- AstraZeneca Plc, the U.K.'s second- largest drugmaker, had a patent protecting the manufacturing of its Symbicort asthma inhaler revoked by European regulators.
